Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of National Health Investors, Inc. (NYSE:NHI). In a filing disclosed on September 04th, the Representative disclosed that they had bought between $1,001 and $15,000 in National Health Investors stock on July 10th. The trade occurred in the Representative's "150 MAIN STREET TRUST > BANK OF AMERICA" account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $15,001 - $50,000 in shares of Mesabi Trust NYSE: MSB on 7/31/2026.
- Purchased $1,001 - $15,000 in shares of Praxis Precision Medicines NASDAQ: PRAX on 7/30/2026.
- Purchased $15,001 - $50,000 in shares of Alkermes NASDAQ: ALKS on 7/30/2026.
- Sold $15,001 - $50,000 in shares of Crinetics Pharmaceuticals NASDAQ: CRNX on 7/30/2026.
- Sold $100,001 - $250,000 in shares of Alibaba Group NYSE: BABA on 7/24/2026.
- Sold $1,001 - $15,000 in shares of Adobe NASDAQ: ADBE on 7/24/2026.
- Sold $1,001 - $15,000 in shares of Viavi Solutions NASDAQ: VIAV on 7/21/2026.
- Purchased $1,001 - $15,000 in shares of SailPoint NASDAQ: SAIL on 7/21/2026.
- Purchased $1,001 - $15,000 in shares of Glacier Bancorp NYSE: GBCI on 7/21/2026.
- Sold $1,001 - $15,000 in shares of FedEx NYSE: FDX on 7/21/2026.
National Health Investors Stock Up 0.0%
NHI stock opened at $70.90 on Tuesday. The company has a current ratio of 6.78, a quick ratio of 6.78 and a debt-to-equity ratio of 0.81. The company's 50-day moving average price is $75.25 and its 200 day moving average price is $77.98. National Health Investors, Inc. has a 52 week low of $67.94 and a 52 week high of $91.38. The company has a market cap of $3.48 billion, a P/E ratio of 20.49, a P/E/G ratio of 3.78 and a beta of 0.52.
National Health Investors (NYSE:NHI - Get Free Report) last posted its earnings results on Monday, August 10th. The real estate investment trust reported $1.19 earnings per share for the quarter. The company had revenue of $121.32 million for the quarter. National Health Investors had a return on equity of 10.89% and a net margin of 38.56%.The firm's revenue for the quarter was up 1.6% on a year-over-year basis. During the same period last year, the company posted $1.22 EPS. National Health Investors has set its FY 2026 guidance at 4.740-4.790 EPS. On average, research analysts expect that National Health Investors, Inc. will post 4.76 earnings per share for the current fiscal year.
National Health Investors Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 6th. Shareholders of record on Wednesday, September 30th will be given a $0.92 dividend. The ex-dividend date is Wednesday, September 30th. This represents a $3.68 annualized dividend and a yield of 5.2%. National Health Investors's dividend payout ratio is presently 106.36%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NHI. BlackRock Inc. purchased a new stake in National Health Investors during the second quarter valued at about $665,997,000. California State Teachers Retirement System raised its holdings in shares of National Health Investors by 7,748.8% in the 2nd quarter. California State Teachers Retirement System now owns 4,077,393 shares of the real estate investment trust's stock worth $310,942,000 after purchasing an additional 4,025,444 shares during the period. State Street Corp lifted its stake in shares of National Health Investors by 5.0% in the 2nd quarter. State Street Corp now owns 2,023,381 shares of the real estate investment trust's stock valued at $143,651,000 after purchasing an additional 95,812 shares in the last quarter. Principal Financial Group Inc. grew its holdings in shares of National Health Investors by 2.0% during the 1st quarter. Principal Financial Group Inc. now owns 1,700,908 shares of the real estate investment trust's stock worth $137,537,000 after purchasing an additional 32,902 shares during the period. Finally, Bank of New York Mellon Corp purchased a new stake in shares of National Health Investors during the 2nd quarter worth about $122,509,000. Institutional investors and hedge funds own 62.51% of the company's stock.
Insider Transactions at National Health Investors
In other National Health Investors news, Director Robert A. Mccabe, Jr. purchased 890 shares of the business's stock in a transaction that occurred on Monday, June 15th. The shares were purchased at an average price of $71.65 per share, for a total transaction of $63,768.50. Following the completion of the acquisition, the director owned 44,159 shares of the company's stock, valued at approximately $3,163,992.35. This represents a 2.06% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.70% of the company's stock.
Analyst Upgrades and Downgrades
NHI has been the topic of several analyst reports. BMO Capital Markets decreased their price objective on National Health Investors from $90.00 to $80.00 and set an "outperform" rating on the stock in a report on Monday, June 15th. Weiss Ratings downgraded National Health Investors from a "buy (b)" rating to a "buy (b-)" rating in a research report on Friday, June 12th. Deutsche Bank Aktiengesellschaft decreased their price target on National Health Investors from $85.00 to $80.00 and set a "hold" rating on the stock in a research note on Thursday, June 25th. Truist Financial dropped their price objective on shares of National Health Investors from $81.00 to $80.00 and set a "buy" rating for the company in a research note on Wednesday, September 2nd. Finally, Wells Fargo & Company cut their price objective on shares of National Health Investors from $79.00 to $78.00 and set an "equal weight" rating on the stock in a report on Tuesday, September 1st. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $83.57.
Get Our Latest Analysis on NHI
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About National Health Investors
(
Get Free Report)
National Health Investors, Inc NYSE: NHI is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company's portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.